Inspire Banner
 
 
First Line Treatment Strategies in EGFRm NSCLC: Osimertinib in the Upfront Approach
26th May, 2021 | Speaker: Associate Professor Virute Sriuranpong
Document ID: SC-SSK-00395
Speaker
Herbert Ho-Fung LOONG
Associate Professor Virute Sriuranpong

Internal Medicine and Medical Oncology
Chulalongkorn University & The King
Chulalongkorn Memorial Hospital
Thailand

more videos
After the EGFR TKIs: Management of Advanced NSCLC Following Progression on EGFR TKIs
 
 

After the EGFR TKIs: Management of Advanced NSCLC Following Progression on EGFR TKIs

26th May, 2021

Speaker: Professor Tony Mok

First Line Treatment Strategies in EGFRm NSCLC: EGFR TKIs-based Combination Treatment
 
 

First Line Treatment Strategies in EGFRm NSCLC: EGFR TKIs-based Combination Treatment

26th May, 2021

Speaker: Dr Nguyen Tuan Khoi